Moderna aims to offset COVID vaccine lawsuit to US govt

Moderna has rejected claims that its COVID-19 vaccine violates the patent rights of two biopharma companies, arguing that its contract with the US federal government has conferred immunity.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Arbutus, Genevant reject Moderna’s vaccine patent defence

7 June 2022 Moderna’s bid to avoid a COVID-19 patent claim has been rejected by two pharma companies that are suing the vaccine manufacturer for infringing its drug delivery technology.

Americas

US govt wades into Moderna COVID row

15 February 2023 The pharma company is accused of using patented tech for a drug-delivery system without authorisation | Moderna sought to escape the suit by claiming that its contract with the US government conferred immunity.

Big Pharma

Moderna and Pfizer face fresh suits over COVID-19 vaccine

30 May 2023 A US biotech is accusing the pair of infringing several of its “foundational” lipid particle patents | Pfizer and BioNTech accused plaintiff in earlier suit of antitrust in a dispute over one of the patents at issue.

More on this story

Big Pharma

Arbutus, Genevant reject Moderna’s vaccine patent defence

7 June 2022 Moderna’s bid to avoid a COVID-19 patent claim has been rejected by two pharma companies that are suing the vaccine manufacturer for infringing its drug delivery technology.

Americas

US govt wades into Moderna COVID row

Big Pharma

Moderna and Pfizer face fresh suits over COVID-19 vaccine

More on this story

Big Pharma

Arbutus, Genevant reject Moderna’s vaccine patent defence

7 June 2022 Moderna’s bid to avoid a COVID-19 patent claim has been rejected by two pharma companies that are suing the vaccine manufacturer for infringing its drug delivery technology.

Americas

US govt wades into Moderna COVID row

Big Pharma

Moderna and Pfizer face fresh suits over COVID-19 vaccine